Microbiology

  1. The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates

    1. Gang Ye
    2. Joseph Gallant
    3. Jian Zheng
    4. Christopher Massey
    5. Ke Shi
    6. Wanbo Tai
    7. Abby Odle
    8. Molly Vickers
    9. Jian Shang
    10. Yushun Wan
    11. Lanying Du
    12. Hideki Aihara
    13. Stanley Perlman
    14. Aaron LeBeau
    15. Fang Li

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation

    1. Lucy G Thorne
    2. Ann‐Kathrin Reuschl
    3. Lorena Zuliani‐Alvarez
    4. Matthew V X Whelan
    5. Jane Turner
    6. Mahdad Noursadeghi
    7. Clare Jolly
    8. Greg J Towers

    Reviewed by ScreenIT

    1 evaluationAppears in 2 listsLatest version Latest activity

  3. A practical PPE decontamination method using warm air and ambient humidity

    1. Jesse J. Kwiek
    2. Christopher R. Pickett
    3. Chloe A. Flanigan
    4. Marcia V. Lee
    5. Linda J. Saif
    6. Jeff Jahnes
    7. Greg Blonder

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Susceptibility of rabbits to SARS-CoV-2

    1. Anna Z. Mykytyn
    2. Mart M. Lamers
    3. Nisreen M. A. Okba
    4. Tim I. Breugem
    5. Debby Schipper
    6. Petra B. van den Doel
    7. Peter van Run
    8. Geert van Amerongen
    9. Leon de Waal
    10. Marion P. G. Koopmans
    11. Koert J. Stittelaar
    12. Judith M. A. van den Brand
    13. Bart L. Haagmans

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture

    1. Kenneth H. Risner
    2. Katie V. Tieu
    3. Yafei Wang
    4. Michael Getz
    5. Allison Bakovic
    6. Nishank Bhalla
    7. Steven D. Nathan
    8. Daniel E. Conway
    9. Paul Macklin
    10. Aarthi Narayanan
    11. Farhang Alem

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative

    1. Sameer Kumar Malladi
    2. Unnatiben Rajeshbhai Patel
    3. Raju S. Rajmani
    4. Randhir Singh
    5. Suman Pandey
    6. Sahil Kumar
    7. Sara Khaleeq
    8. Petrus Jansen van Vuren
    9. Shane Riddell
    10. Sarah Goldie
    11. Savitha Gayathri
    12. Debajyoti Chakraborty
    13. Parismita Kalita
    14. Ishika Pramanick
    15. Nupur Agarwal
    16. Poorvi Reddy
    17. Nidhi Girish
    18. Aditya Upadhyaya
    19. Mohammad Suhail Khan
    20. Kawkab Kanjo
    21. Madhuraj Bhat
    22. Shailendra Mani
    23. Sankar Bhattacharyya
    24. Samreen Siddiqui
    25. Akansha Tyagi
    26. Sujeet Jha
    27. Rajesh Pandey
    28. Shashank Tripathi
    29. Somnath Dutta
    30. Alexander J. McAuley
    31. Nagendrakumar Balasubramanian Singanallur
    32. Seshadri S. Vasan
    33. Rajesh P. Ringe
    34. Raghavan Varadarajan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades ago

    1. Min Qiang
    2. Peixiang Ma
    3. Yu Li
    4. Hejun Liu
    5. Adam Harding
    6. Chenyu Min
    7. Lili Liu
    8. Meng Yuan
    9. Qun Ji
    10. Pingdong Tao
    11. Xiaojie Shi
    12. Zhean Li
    13. Fulian Wang
    14. Yu Zhang
    15. Nicholas C. Wu
    16. Chang-Chun D. Lee
    17. Xueyong Zhu
    18. Javier Gilbert-Jaramillo
    19. Abhishek Saxena
    20. Xingxu Huang
    21. Hou Wang
    22. William James
    23. Raymond A. Dwek
    24. Ian A. Wilson
    25. Guang Yang
    26. Richard A. Lerner

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate

    1. Devanshi R. Patel
    2. Cassandra J. Field
    3. Kayla M. Septer
    4. Derek G. Sim
    5. Matthew J. Jones
    6. Talia A. Heinly
    7. Thomas H. Vanderford
    8. Elizabeth A. McGraw
    9. Troy C. Sutton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine

    1. Yasunori Watanabe
    2. Luiza Mendonça
    3. Elizabeth R. Allen
    4. Andrew Howe
    5. Mercede Lee
    6. Joel D. Allen
    7. Himanshi Chawla
    8. David Pulido
    9. Francesca Donnellan
    10. Hannah Davies
    11. Marta Ulaszewska
    12. Sandra Belij-Rammerstorfer
    13. Susan Morris
    14. Anna-Sophia Krebs
    15. Wanwisa Dejnirattisai
    16. Juthathip Mongkolsapaya
    17. Piyada Supasa
    18. Gavin R. Screaton
    19. Catherine M. Green
    20. Teresa Lambe
    21. Peijun Zhang
    22. Sarah C. Gilbert
    23. Max Crispin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure

    1. Emma K. Loveday
    2. Kyle S. Hain
    3. Irina Kochetkova
    4. Jodi F. Hedges
    5. Amanda Robison
    6. Deann T. Snyder
    7. Susan K. Brumfield
    8. Mark J. Young
    9. Mark A. Jutila
    10. Connie B. Chang
    11. Matthew P. Taylor

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 168 of 255 Next